Filter
1427
Text search:
drug
approval
Featured
Recommendations
95
New Publications
409
Language
Document type
No document type
838
Studies & Reports
258
Guidelines
180
Manuals
61
Strategic & Response Plan
40
Fact sheets
26
Training Material
15
Resource Platforms
4
Situation Updates
3
Brochures
1
Infographics
1
Countries / Regions
India
93
Global
47
Uganda
43
Kenya
42
Nigeria
37
South Africa
36
Malawi
34
Ethiopia
31
Nepal
28
Western and Central Europe
28
Myanmar / Burma
26
Tanzania
25
Sierra Leone
24
Liberia
23
Ghana
22
Zambia
22
Ukraine
22
Bangladesh
21
Rwanda
20
Namibia
19
Latin America and the Carribbean
18
Lesotho
16
Zimbabwe
14
Africa
14
South–East Asia Region
13
Eastern Europe
12
Botswana
11
Congo, Democratic Republic of
9
Burkina Faso
8
Philippines
8
Cambodia
8
Asia
8
Senegal
7
Thailand
6
Pakistan
5
Syria
5
China
5
Mozambique
5
Benin
5
Tajikistan
5
Russia
5
USA
4
Cameroon
4
South Sudan
4
Indonesia
4
Peru
4
East and Southern Africa
4
Albania
4
Germany
3
Eswatini/ Swaziland
3
West and Central Africa
3
Venezuela
3
Georgia
3
Vietnam
3
Somalia
2
Central African Republic
2
El Salvador
2
Mexico
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Bhutan
2
Laos
2
Moldova
2
Jamaica
2
Guinea
1
Iraq
1
Afghanistan
1
Lebanon
1
Sudan
1
Argentina
1
Brazil
1
Colombia
1
Libya
1
Sri Lanka
1
Chile
1
Yemen
1
Western Pacific Region
1
Paraguay
1
Fiji
1
Palestine
1
Armenia
1
Qatar
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
North America
1
Turkmenistan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
629
Clinical Guidelines
118
Public Health
41
Key Resources
38
Women & Child Health
35
Pharmacy & Technologies
33
Capacity Building
13
Toolboxes
HIV
176
TB
134
AMR
102
Mental Health
72
COVID-19
72
Pharmacy
64
NTDs
54
Ebola & Marburg
25
NCDs
24
Rapid Response
22
Caregiver
21
Health Financing Toolbox
17
Planetary Health
16
Malaria
15
Global Health Education
12
Conflict
11
Refugee
11
2.0 Rapid Response
10
Disability
9
Zika
7
Polio
5
Natural Hazards
4
Specific Hazards
4
Cholera
1
Social Ethics
1
DOI: 10.5772/intechopen.102891Little progress has been made since the 1960s and 19. 70s to widen the therapeutic arsenal against Trypanosoma cruzi, the causative pathogen of Chagas disease, which remains a frustrating and perplexing infectious disease. This chapter focuses on the strategic and opera
...
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.
Many vaccines and drugs hold the promise of reducing mortality and morbidity among pregnant women and infants living in low- and middle-income countries (LMICs). However, sufficient information on the safety of drugs and vaccines in pregnant women is rarely available at the time of product licensure
...
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
Three Years After Enactment of the Drug Quality and Security Act
A survival guide for clinicans.
3rd edition.
First Revised Edition
March 2000
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
A new formulation of a drug to prevent excessive bleeding following childbirth could save thousands of women’s lives in low- and lower-middle-income countries, according to a study led by the World Health Organization (WHO) in collaboration with M
...
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping lab
...
CHAPTER 206 | An Act to establish a national drug policy and a national drug authority to ensure the availability, at all times, of essential, efficacious and cost-effective drugs to the entire popu
...